Cargando…
Estrogen receptor targeting with genistein radiolabeled Technetium-99(m) as radiotracer of breast cancer: Its optimization, characterization, and predicting stability constants by DFT calculation
OBJECTIVE: Genistein is an isoflavone molecule with a high affinity for estrogen receptors (ER), which could lead to the mechanism of selective estrogen receptor modulators (SERMs) in breast cancer. Genistein labeling with technetium-99(m) can be a new promising strategy for diagnostic breast cancer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898673/ https://www.ncbi.nlm.nih.gov/pubmed/36747562 http://dx.doi.org/10.1016/j.heliyon.2023.e13169 |
Sumario: | OBJECTIVE: Genistein is an isoflavone molecule with a high affinity for estrogen receptors (ER), which could lead to the mechanism of selective estrogen receptor modulators (SERMs) in breast cancer. Genistein labeling with technetium-99(m) can be a new promising strategy for diagnostic breast cancer. In this research, we evaluate the physicochemical characteristics of the [(99m)Tc]Tc-genistein complex and describe the optimal labeling method parameters. We also calculated density functional theory to study the stability constants to support complex formation analysis (DFT). METHODS: The genistein was directly labeled with (99m)Tc, and its stability as well as its potential for usage as a radiotracer were all investigated. DFT calculations with thermodynamic cycles to determine chemical coordination models and calculate thermodynamic constants of complex more accurately. RESULTS: The radiochemical purity of [(99m)Tc]Tc-genistein showed a high yield of 93.25% ± 0.30% and had good physicochemical properties. The stability of the Tc(IV)-genistein complex was confirmed by DFT calculations at a value of 99.0822. CONCLUSIONS: As a result, [(99m)Tc]Tc-genistein could be a potential radiotracer kit for SPECT imaging of breast cancer. |
---|